Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Expert Opinion on Pharmacotherapy
|
March 7, 2013
Pimecrolimus for psoriasis
Jean Ayer, Helen S Young
Experimental Dermatology
|
February 4, 2017
Excessive angiogenesis associated with psoriasis as a cause for cardiovascular ischaemia
Nina Malecic, Helen S Young
Drugs
|
September 4, 2012
Current and emerging systemic treatment strategies for psoriasis
Philip M Laws, Helen S Young
Clinical, Cosmetic and Investigational Dermatology
|
March 26, 2011
Update of the management of chronic psoriasis: new approaches and emerging treatment options
Philip M Laws, Helen S Young
Expert Opinion on Pharmacotherapy
|
June 24, 2010
Topical treatment of psoriasis
Philip M Laws, Helen S Young
The British Journal of Dermatology
|
December 8, 2021
Antivascular endothelial growth factor-A therapy: a novel personalized treatment approach for psoriasis
Andrea Luengas-Martinez, Ralf Paus, Helen S Young
BMC Medical Education
|
January 9, 2021
The impact of research intercalation during medical school on post-graduate career progression
Antony K Sorial, Morgan Harrison-Holland, Helen S Young
Skin Health and Disease
|
October 6, 2023
Inhibition of vascular endothelial growth factor-A downregulates angiogenesis in psoriasis: A pilot study
Andrea Luengas-Martinez, Dina Ismail, Ralf Paus, et al.
Skin Health and Disease
|
December 3, 2024
Vascular endothelial growth factor A inhibition remodels the transcriptional signature of lipid metabolism in psoriasis non-lesional skin in 12 h ex vivo culture
Andrea Luengas-Martinez, Dina Ismail, Ralf Paus, et al.
Experimental Dermatology
|
July 13, 2020
Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis
Andrea Luengas-Martinez, Jonathan Hardman-Smart, Ralf Paus, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Expert Opinion on Pharmacotherapy
|
March 7, 2013
Pimecrolimus for psoriasis
Jean Ayer, Helen S Young
Experimental Dermatology
|
February 4, 2017
Excessive angiogenesis associated with psoriasis as a cause for cardiovascular ischaemia
Nina Malecic, Helen S Young
Drugs
|
September 4, 2012
Current and emerging systemic treatment strategies for psoriasis
Philip M Laws, Helen S Young
Clinical, Cosmetic and Investigational Dermatology
|
March 26, 2011
Update of the management of chronic psoriasis: new approaches and emerging treatment options
Philip M Laws, Helen S Young
Expert Opinion on Pharmacotherapy
|
June 24, 2010
Topical treatment of psoriasis
Philip M Laws, Helen S Young
The British Journal of Dermatology
|
December 8, 2021
Antivascular endothelial growth factor-A therapy: a novel personalized treatment approach for psoriasis
Andrea Luengas-Martinez, Ralf Paus, Helen S Young
BMC Medical Education
|
January 9, 2021
The impact of research intercalation during medical school on post-graduate career progression
Antony K Sorial, Morgan Harrison-Holland, Helen S Young
Skin Health and Disease
|
October 6, 2023
Inhibition of vascular endothelial growth factor-A downregulates angiogenesis in psoriasis: A pilot study
Andrea Luengas-Martinez, Dina Ismail, Ralf Paus, et al.
Skin Health and Disease
|
December 3, 2024
Vascular endothelial growth factor A inhibition remodels the transcriptional signature of lipid metabolism in psoriasis non-lesional skin in 12 h ex vivo culture
Andrea Luengas-Martinez, Dina Ismail, Ralf Paus, et al.
Experimental Dermatology
|
July 13, 2020
Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis
Andrea Luengas-Martinez, Jonathan Hardman-Smart, Ralf Paus, et al.
Page
of 4